Treatment of Moderate FMR During AVR
Not yet recruiting
- Conditions
- Functional Mitral Regurgitation
- Registration Number
- NCT05566340
- Lead Sponsor
- Fuwai Yunnan Cardiovascular Hospital
- Brief Summary
Debates exist on the treatment of moderate functional mitral regurgitation (FMR) in patients undergoing aortic valve replacement (AVR) for aortic valve disease. This study aims to evaluate the left ventricular function, which was evaluated through global longitudinal strain, after isolated AVR and AVR + mitral valve repair (MVr) in this group of patients.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- NOT_YET_RECRUITING
- Sex
- All
- Target Recruitment
- 154
Inclusion Criteria
- Patients who received AVR (with or without concomitant MVr) from two center (Fuwai Yunnan Cardiovascular Hospital and Fuwai Hospital, Chinese Academy of Medical Sciences).
- Age more than 18 years.
Exclusion Criteria
- Those with a history of rheumatic valvular disease or infective endocarditis.
- Primary mitral valve lesions.
- Patients receiving mitral valve replacement.
- Patient who refuse to participate in this study, or cannot complete 6-month follow-up after surgery.
- Age < 18 years.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method left ventricular global longitudinal strain 10/10/2022-10/10/2023 The change of left ventricular global longitudinal strain compared to before surgery
- Secondary Outcome Measures
Name Time Method